Austar Lifesciences Limited (HKG:6118)
Hong Kong · Delayed Price · Currency is HKD 0.7100
-0.0100 (-1.39%)
Jul 31, 2026, 11:11 AM HKT
Austar Lifesciences Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,531 | 1,531 | 1,500 | 1,764 | 2,157 | 2,015 |
Revenue Growth | 4.74% | 2.02% | -14.93% | -18.23% | 7.04% | 55.48% |
Gross Profit Gross Profit Growth | 293.27 | 293.27 | 301.22 | 336.05 | 488.8 | 479.01 |
Operating Income Operating Income Growth | 43.1 | 43.1 | 34.77 | -41.21 | 122.79 | 116.97 |
Net Income Net Income Growth | 33.81 | 33.81 | 16.08 | -113.47 | 87.46 | 277.3 |
Earnings Per Share EPS Growth | 0.07 | 0.07 | 0.03 | -0.22 | 0.17 | 0.54 |
EPS Growth | -3.96% | 110.25% | - | - | -68.40% | 800.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Inter-Segment Inter-Segment Growth | -314.94 | -314.94 | -278.51 | -275.54 | -306.82 | -164.8 |
Life Science Equipment and Consumables Life Science Equipment and Consumables Growth | 329.65 | 329.65 | 346.16 | 321.78 | 391.81 | 428.39 |
Consulting,digitalization and Construction Consulting,digitalization and Construction Growth | 509.58 | 509.58 | 611.42 | 732.65 | - | - |
Integrated Process and Packaging Systems Integrated Process and Packaging Systems Growth | 1,006 | 1,006 | 821.33 | 984.85 | - | - |
Total Total Growth | 1,531 | 1,531 | 1,500 | 1,764 | 2,157 | 2,015 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 227.39 | 227.39 | 167.81 | 173.77 | 148.13 | 219.74 |
Total Debt Total Debt Growth | 343.68 | 343.68 | 401.95 | 496.2 | 336.55 | 155.22 |
Net Cash (Debt) Net Cash Growth | -116.28 | -116.28 | -234.15 | -322.43 | -188.42 | 64.52 |
Net Cash Growth | - | - | - | - | - | -36.53% |
Net Cash Per Share Net Cash Per Share Growth | -0.23 | -0.23 | -0.46 | -0.63 | -0.37 | 0.13 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 132.1 | 132.1 | 98.81 | -62.65 | -37.93 | -103.45 |
Capital Expenditures CapEx Growth | -23.1 | -23.1 | -20.49 | -69.24 | -117.11 | -100.57 |
Free Cash Flow Free Cash Flow Growth | 109 | 109 | 78.31 | -131.88 | -155.04 | -204.02 |
Free Cash Flow Growth | 18.43% | 39.18% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.16% | 19.16% | 20.08% | 19.05% | 22.66% | 23.77% |
Operating Margin | 2.82% | 2.82% | 2.32% | -2.34% | 5.69% | 5.80% |
Pretax Margin | 3.14% | 3.14% | 1.41% | -1.95% | 5.54% | 15.84% |
Profit Margin | 2.21% | 2.21% | 1.07% | -6.43% | 4.06% | 13.76% |
FCF Margin | 7.12% | 7.12% | 5.22% | -7.48% | -7.19% | -10.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.67 | 11.85 | 17.08 | - | 10.47 | 22.71 |
Forward PE | - | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 |
P/FCF Ratio | 3.00 | 3.68 | 3.51 | - | - | - |
PS Ratio | 0.21 | 0.26 | 0.18 | 0.41 | 0.43 | 3.13 |